BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 35117544)

  • 1. Prevalence and genotypes of human papilloma virus infection in CIN3 in Beijing, China.
    Zhao XY; Kong WM; Jiao SM; Song D; Chen J; Shang RT
    Transl Cancer Res; 2020 Mar; 9(3):1978-1984. PubMed ID: 35117544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
    Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
    Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52.
    Wang X; Han S; Li X; Wang X; Wang S; Ma L
    Virol J; 2022 Mar; 19(1):37. PubMed ID: 35246180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Positive Human Papillomavirus Status After Conization and Disease Recurrence in Patients with Cervical Intraepithelial Neoplasia Grade 3.
    Kamio M; Yanazume S; Togami S; Kobayashi H
    J Obstet Gynaecol India; 2021 Feb; 71(1):66-71. PubMed ID: 33814801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection Modes and Subtypes of Human Papilloma Virus in Patients.
    Zhang R; Bi XX; Ye A; Kong LJ; Dou YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):506-510. PubMed ID: 28877828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.
    Anastos K; Hoover DR; Burk RD; Cajigas A; Shi Q; Singh DK; Cohen MH; Mutimura E; Sturgis C; Banzhaf WC; Castle PE
    PLoS One; 2010 Oct; 5(10):e13525. PubMed ID: 20976000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.
    Petry KU; Luyten A; Justus A; Iftner A; Strehlke S; Reinecke-Lüthge A; Grunwald E; Schulze-Rath R; Iftner T
    BMC Infect Dis; 2013 Mar; 13():135. PubMed ID: 23497108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening.
    Kitchener HC; Almonte M; Gilham C; Dowie R; Stoykova B; Sargent A; Roberts C; Desai M; Peto J;
    Health Technol Assess; 2009 Nov; 13(51):1-150, iii-iv. PubMed ID: 19891902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of reflex HPV16/18 genotyping in predicting CIN3/VAIN3 in women with HPV+/Pap- results.
    Guo M; Khanna A; Dawlett M; Patel S; Gong Y; Staerkel G
    J Am Soc Cytopathol; 2016; 5(1):31-36. PubMed ID: 31042536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of human papillomavirus genotypes in cervical lesions.
    Ma L; Cong X; Shi M; Wang XH; Liu HY; Bian ML
    Exp Ther Med; 2017 Feb; 13(2):535-541. PubMed ID: 28352328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical Cancers Manifest a High Rate of Infection by a High-Risk Human Papilloma Virus Subtype but a Very Low Rate of Infection by a Low-Risk Subtype in the Guiyang District of China.
    Peng J; Yuan Y; Shen F; Wang Y; Chen L; Liao DJ; Tan Y
    J Cancer; 2017; 8(7):1263-1270. PubMed ID: 28607602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of HR-HPV infection based on self-sampling among women in China exhibited some unique epidemiologic features.
    Du H; Luo H; Wang C; Qu X; Belinson JL; Wu R
    J Clin Epidemiol; 2021 Nov; 139():319-329. PubMed ID: 34161804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Genotype Distribution of Human Papillomavirus Among Healthy Females in Beijing, China, 2016-2019.
    Yu H; Yi J; Dou YL; Chen Y; Kong LJ; Wu J
    Infect Drug Resist; 2021; 14():4173-4182. PubMed ID: 34675562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of the Interaction between Human Papillomavirus (HPV) Type 16 and Other High-Risk Human Papillomaviruses in Women with Cervical Intraepithelial Neoplasia (CIN) and Invasive Cervical Cancer.
    Spinillo A; Dominoni M; Boschi AC; Sosso C; Fiandrino G; Cesari S; Gardella B
    J Oncol; 2020; 2020():6508180. PubMed ID: 33178274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China.
    Chen Q; Xie LX; Qing ZR; Li LJ; Luo ZY; Lin M; Zhang SM; Chen WZ; Lin BZ; Lin QL; Li H; Chen WP; Zheng PY; Mao LZ; Chen CY; Yang C; Zhan YZ; Liu XZ; Zheng JK; Yang LY
    PLoS One; 2012; 7(2):e32149. PubMed ID: 22384160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia.
    Adcock R; Cuzick J; Hunt WC; McDonald RM; Wheeler CM;
    Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1816-1824. PubMed ID: 31488417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.
    Xu HH; Wang K; Feng XJ; Dong SS; Lin A; Zheng LZ; Yan WH
    Oncotarget; 2018 Mar; 9(20):15386-15397. PubMed ID: 29632652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and genotype distribution of HPV infection among 214,715 women from Southern China, 2012-2018: baseline measures prior to mass HPV vaccination.
    Luo LP; He P; Liu QT; Jiang YH; Zhang YN; Li QZ; Li Q; Li ST; Yang F; Ling H; Dai XG; Li ZY; Chen HL
    BMC Infect Dis; 2021 Apr; 21(1):328. PubMed ID: 33827456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
    Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
    APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.